Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection ; volume:7 ; number:1 ; day:11 ; month:5 ; year:2010 ; pages:1-2 ; date:5.2010
Retrovirology ; 7, Heft 1 (11.5.2010), 1-2, 5.2010
- Urheber
-
Manfredi, Roberto
- Beteiligte Personen und Organisationen
-
Dentale, Nicola
Calza, Leonardo
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-7-S1-P86
- URN
-
urn:nbn:de:1111-2016080714362
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Manfredi, Roberto
- Dentale, Nicola
- Calza, Leonardo
- SpringerLink (Online service)
Ähnliche Objekte (12)
HIV-HCV Co-infection Among Blood Donors
HCV co-infection in HIV positive population in British Columbia, Canada
Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
HCV co-infection is related to acute ischemic severity and outcome
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype
HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection
HTLV-1 infection modulates the immune response in HIV-HCV coinfected patients and may increase spontaneous HCV clearance
HCV-specific T cell responses during and after chronic HCV infection
Managing HCV infection: present and future
HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination
Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic
HIV-HCV Co-infection Among Blood Donors
HCV co-infection in HIV positive population in British Columbia, Canada
Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
HCV co-infection is related to acute ischemic severity and outcome
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype
HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection
HTLV-1 infection modulates the immune response in HIV-HCV coinfected patients and may increase spontaneous HCV clearance
HCV-specific T cell responses during and after chronic HCV infection
Managing HCV infection: present and future
HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination
Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic
HIV-HCV Co-infection Among Blood Donors
HCV co-infection in HIV positive population in British Columbia, Canada
Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
HCV co-infection is related to acute ischemic severity and outcome
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype
HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection
HTLV-1 infection modulates the immune response in HIV-HCV coinfected patients and may increase spontaneous HCV clearance
HCV-specific T cell responses during and after chronic HCV infection
Managing HCV infection: present and future
HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination